Autoreactive T cells in a partially humanized murine model of T1D

Annals of the New York Academy of Sciences

Volumn 1103, Issue , 2007, Pages 69-76

  Gebe, John A ^a   Falk, Ben ^a   Unrath, Kellee ^a   Nepom, Gerald T ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Diabetes; GAD65; HLA DR4; Tolerance

Indexed keywords

EPITOPE; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; HLA DR4 ANTIGEN; INSULIN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUCOSE TOLERANCE TEST; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; RISK FACTOR; T LYMPHOCYTE; TRANSGENIC MOUSE;

MURINAE; MUS; MUS MUSCULUS;

EID: 34249023332     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1394.001     Document Type: Article

References (28)

1. ENDL, J., H. OTTO, & G. JUNG, et al. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99: 2405-2415.
2. LOHMANN, T., R. D. LESLIE, & M. HAWA, et al. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343: 1607-1608.
3. RHARBAOUI, F., A. MAYER, & C. GRANIER, et al. 1999. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes. Clin. Exp. Immunol. 117: 30-37.
4. ARMSTRONG, N.W. & D.B. JONES. 1994. Epitopes of GAD 65 in insulin-dependent diabetes mellitus. Lancet 344: 406-407.
5. YOON, J.W., C.S. YOON, & H.W. LIM, et al. 1999. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284: 1183-1187.
6. PATEL, S.D., A.P. COPE, & M. CONGIA, et al. 1997. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101, beta1*0401) transgenic mice. Proc. Natl. Acad. Sci. USA 94: 8082-8087.
7. NEPOM, G.T., J.D. LIPPOLIS, & F.M. WHITE, et al. 2001. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc. Natl. Acad. Sci. USA 98: 1763-1768.
8. REIJONEN, H., E.J. NOVAK, & S. KOCHIK, et al. 2002. Detection of GAD65 specific T-cells by MHC class II multimers in type 1 diabetes patients and at-risk subjects. Diabetes 51: 1375-1382.
9. OLING, V., J.MARTTILA, & J. ILONEN, et al. 2005. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25: 235-243.
10. REIJONEN, H., W.W. KWOK & G.T. NEPOM. 2003. Detection of CD4 +autoreactive T cells in T1D using HLA class II tetramers. Ann. N. Y. Acad. Sci. 1005: 82-87.
11. REIJONEN, H., R. MALLONE, & A.K. HENINGER, et al. 2004. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53: 1987-1994.
12. TISCH, R., X.D. YANG, & S.M. SINGER, et al. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
13. KAUFMAN, D.L., M. CLARE-SALZLER, & J. TIAN, et al. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
14. WEN, L., F.S. WONG, & J. TANG, et al. 2000. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J. Exp. Med. 191: 97-104.
15. GEBE, J.A., K.A. UNRATH, & B.A. FALK, et al. 2006. Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabeticprone RIP-B7/DR4 mice. Clin. Immunol. 121: 294-304.
16. WEN, L., N.Y. CHEN, & J. TANG, et al. 2001. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest 107: 871-880.
17. KENT, S.C., Y. CHEN, & L. BREGOLI, et al. 2005. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435: 224-228.
18. GEBE J.A., B.A. FALK, & K.A. UNRATH, et al. 2007. Impaired islet function in DR4-restricted GAD65 TcR transgenic DR4 mice. Submitted for publication.
19. SCHMIDT, D., J. VERDAGUER, N. AVERILL & P. SANTAMARIA. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186: 1059-1075.
20. VERDAGUER, J., J.W. YOON, & B. ANDERSON, et al. 1996. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J. Immunol. 157: 4726-4735.
21. VERDAGUER, J., D. SCHMIDT, & A. AMRANI, et al. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
22. KANAGAWA, O., J. SHIMIZU & B.A. VAUPEL. 2000. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice. J. Immunol. 164: 5466-5473.
23. TRUDEAU, J.D., C. KELLY-SMITH, & C. B. VERCHERE, et al. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111: 217-223.
24. HASKINS, K. 2004. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones. J. Autoimmun. 22: 107-109.
25. PAUZA, M.E., C.M. DOBBS, & J. HE, et al. 2004. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53: 978-988.
26. TARBELL, K.V., M. LEE, & E. RANHEIM, et al. 2002. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196: 481-492.
27. DANKE, N.A., D.M. KOELLE, & C. YEE, et al. 2004. Autoreactive T cells in healthy individuals. J. Immunol. 172: 5967-5972.
28. MCCULLOCH, D.K., L.J. KLAFF, & S.E. KAHN, et al. 1990. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 39: 549-556.